It is time to ask what adenosine can do for cardioprotection

Heart and Vessels

Volumn 13, Issue 5, 1998, Pages 211-228

  Kitakaze, Masafumi ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenosine; Chronic heart failure; Clinical trial; Collateral; Ecto 5' nucleotidase; Growth factor; Preconditioning; Protein kinase C

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ECTO 5' NUCLEOTIDASE; GROWTH FACTOR; PROTEIN KINASE C;

ACUTE HEART INFARCTION; COLLATERAL CIRCULATION; DISEASE SEVERITY; HEART FAILURE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0032321615     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03257244     Document Type: Review

References (129)

1. Hori M, Kitakaze (1991) Adenosine, the heart and coronary circulation (brief review). Hypertension 18:565-574
2. Kitakaze M, Hori M, Kamada T (1993) The role of adenosine and its interaction with alpha-adrenoceptor activity in myocardial ischemic and reperfusion injury (brief review). Cardiovasc Res 27:18-27
3. Mubagwa K, Mullane K, Flameng W (1996) Role of adenosine in the heart and circulation. Cardiovasc Res 32:797-813
4. Lagerkranser N, Sollevi A, Irestedt L, Tidgren B, Andreen M (1985) Renin release during controlled hypotension with sodium nitroprusside, nitroglycerin and adenosine: a comparative study in dogs. Acta Anaesthesiol Scand 29:45-49
5. Parmely MJ, Zhou WW, Edward CK III, Borcherding DR, Silverstein R, Morrison DC (1993) Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor riecrotic factor-α production and protect mice against endotoxin challenge. J Immunol 151:389-396
6. Fischer S, Knoll R, Renz D, Karliczek GF, Schaper W (1997) Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells. Endothelium 1997;5(4):373
7. Dusseuau JW, Hutchins M, Malbasa DS (1986) Stimulation of angiogenesis by adenosine on the chick chorioallantonic membrane. Circ Res 59:163-170
8. Meinnger CJ, Schelling ME, Granger HJ (1988) Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255:H554-H562
9. Meinnger CJ, Granger HJ (1990) Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 258:H198-H206
10. Ohisalo JJ (1987) Regulatory functions of adenosine. Med Biol 65:181-191
11. Londos C, Wolff J (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 74:5482-5486
12. Londos C, Cooper DMF, Schlegel W, Rodbell M (1978) Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci USA 75:5362-5366
13. Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70:761-845
14. Degenring FH (1976) The effect of acidosis and alkalosis on coronary flow and cardiac nucleotide metabolism. Basic Res Cardiol 71:287-290
15. 2-Adrenoceptor stimulation can augment coronary vasodilation maximally induced by adenosine in dogs. Am J Physiol 257:H132-H140
16. 2-Adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol 255:H250-H260
17. 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs. Circ Res 65:1632-1645
18. Nayler WG, Price JM, Lowe TE (1967) Inhibition of adenosine-induced coronary vasodilation. Cardiovasc Res 1:63-66
19. Achterberg PW, de Tombep P, Harmsen E, de Jong JW (1985) Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochim Biophys Acta 840:393-400
20. Sparks HV Jr, Bardenheuer H (1986) Regulation of adenosine formation in the heart. Circ Res 58:193-201
21. Llyod GE, Scharader J (1987) The importance of the transmethylation pathway for adenosine metabolism in the heart. In: Gerlach E, Becker BF. (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg, pp 199-207
22. Deussen A, Borst M, Schrader J (1988) Formation of adenosylhomocysteine in the heart. I: an index intracellular adenosine. Circ Res 63:240-249
23. Rubio R, Wiedmeier VT, Berne RM (1974) Relationship between coronary flow and adenosine production and release. J Mol Cell Cardiol 6:561-566
24. Wadsworth RM (1989) The effects of aminophylline on the increased myocardial blood flow produced by systemic hypoxia or by coronary artery occlusion. Eur Pharmacol 20:130-132
25. Wei HM, Kang YH, Merrill GF (1989) Canine coronary vasodepressor response to hypoxia are abolished by 8-phenyltheophylline. Am J Physiol 257:H1043-H1048
26. Curnish RR, Berne RM, Rubio R (1972) Effects of aminophylline on myocardial reactive hyperemia. Proc Soc Exp Biol Med 141:593-598
27. Merrill GF, Downey F, Jones CE (1986) Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol 250:H579-H583
28. Wei HM, Kang YH, Merill GF (1988) Coronary vasodilation during global myocardial hypoxia: Effect of adenosine deaminase. Am J Physiol 254:H1004-H1009
29. Rubio R, Berne RM (1975) Regulation of coronary blood flow. Prog Cardiovasc Dis 8:105-122
30. 1-Adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ Res 60:631-639
31. Hori M, Tamai J, Kitakaze M, Iwakura K, Gotoh K, Iwai K, Koretsune Y, Kagiya T, Kitabatake A, Kamada T (1989) Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol 257:H244-H251
32. Buxton ILO, Walther J, Westfall DP (1990) Purinergic mechanisms in cardiac blood vessels: stimulation of endothelial cell alpha receptors in vitro by the neurotransmitter norepinephrine leads to the rapid release of ATP and its subsequent breakdown to adenosine (abstract). Heart Vessels 4 (Suppl):27
33. 1-Adrenoceptor activation increases ectosolic 5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91:2226-2234
34. Kitakaze M, Minamino T, Node K, Komamura K, Inoue M, Hori M, Kamada T (1996) Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 28:1945-1955
35. Hermann SC, Feigl EO (1992) Adrenergic blockade blunts adenosine concentration and coronary vasodilation during hypoxia. Circ Res 70:1203-1216
36. Watanabe E, Smith DM, Sun J, Smart FW, Delcarpio JB, Roberts TB, Van Meter CH Jr, Claycomb WC (1998) Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Basic Res Cardiol 93:30-37
37. Schaper W (1991) Angiogenesis in the adult heart. Basic Res Cardiol 86 Suppl 2:51-56
38. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM (1998) Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804
39. Yanagisawa MA, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403
40. Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A, Marikovsky M (1998) Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett 425:441-447
41. Sasayama S, Fujita M (1992) Recent insights into coronary collateral circulation. Circulation 85:1197-1204
42. Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N, Nishikawa SI (1999) Maturation of embryonic stem cells into endothelial cells in an In vitro model of vasculogenesis. Blood 93(4):1253-1263
43. Symons JD, Firoozmand E, Longhurst JC (1993) Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role for adenosine. Circ Res 73:503-513
44. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
45. 1 adenosine receptors in rabbit heart. Circulation 84:350-356
46. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O (1992) Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 86:979-985
47. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mon M, Inoue M, Kamada T (1994) The infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89:1237-1246
48. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A (1995) Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76:73-81
49. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T (1996) The role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 93:781-791
50. Kitakaze M, Funaya H, Minamino T, Node K, Sato H, Ueda Y, Okuyama Y, Kuzuya T, Hori M, Yoshida K (1997) Role of Protein kinase C-α in activation of ecto5′-nucleotidase in the preconditioned canine myocardium. Biochem Biophys Res Commun 239:171-175
51. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75:576-585
52. Armstrong S, Ganote CE (1995) In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effect of selective adenosine receptor blockade and calphostin C. Cardiovasc Res 29:647-652
53. Marbar MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress associated with resistance to myocardial infarction. Circulation 83:13-25
54. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M (1993) Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72:1293-1299
55. Sakaguchi T, Sawa Y, Misahimura M, Amemiya A, Ueda H, Ueno Y, Matsuda H (1998) Ecto-5′-nucleotidase activated by heat shock protein 70 attenuates ischemia and reperfusion injury in myocardium. Evidence for a mechanism of second window protection Circulation 98:I-527
56. Kitakaze M, Hori M, Takashima S, Iwai K, Sato H, Inoue M, Kitabatake K, Kamada T (1992) Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs: A role of 5′-nucleotidase activity. Circ Res 71:558-566
57. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 93:2197-2205
58. + channel by protein kinase C. Circ Res 75:999-1005
59. + channels by protein kinase C. Circ Res 83:110-114
60. Liu Y, Sato T, O'Rourke B, Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97:2463-2469
61. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T (1993) Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implication for myocardial salvage. Circulation 87:208-215
62. Zahler S, Becker BF, Raschke P, Gerlach E (1994) Stimulation of endothelial adenosine A, receptors enhances adhesion of neutrophils in intact guinea pig coronary system. Cardiovasc Res 28:1366-1372
63. Zhao J, Renner O, Latchman DS, Marber M (1997) The role of adenosine in the mediation of the resistance to simulated ischemia that follows expression of constitutively active PDC-δ. Circulation 96:1-450
64. Zhao J, Heads RJ, Wightman L, Marber M (1998) PKC-mediated cardioprotection requires adenosine receptor reoccupation (abstract). Circulation 98:I-71
65. Van Wylen DGL (1994). Effects of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia Circulation 89:2283-2289
66. Przyklenk K, Hata K, Zhas L, Kloner RA, Elliott GT (1997) Disparate effects of preconditioning and MLA on 5′-NT and adenosine levels during coronary occlusion. Am J Physiol 273:H945-H951
67. Wolfe Cl, Sievers RE, Visseren FLJ, Donnelly TJ (1993) Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87:881-892
68. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Am J Physiol 260:H796-H804
69. Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T (1996) Cardioprotection due to ischemic preconditioning correlates with increased of ecto-5′-nucleotidase activity. Am J Physiol 270:H238-H244
70. Kitakaze M, Mori H, Sakamoto H, Inoue M (1995) Disappearance of infarct size-limiting effect of ischemic preconditioning is attributable to dephosphorylation process of ecto-5′-nucleotidase. Circulation 92 (Suppl I):I-524
71. Minamino T, Kitakaze M, Node K, Komamura K, Shinozaki Y, Chujo M, Mori H, Hori M, Kamada T (1994) Potentiation of adenosine release slows the natural decay of cardioprotection of ischemic preconditioning: role of activation of ectosolic 5′-nucleotidase (abstract). Eur Heart J 15 (Abstract Suppl):553
72. Olafsson B, Forman MB, Puett DW, Pou A, Gates CU, Friesinger GC, Virmani R (1987) Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135-1145
73. AI-Awqati Q (1995) regulation of ion channels by ABC transporter that secrete ATP. Science 269:805-806
74. 3H]NECA in rat striatal membranes. Mol Pharmacol 29:331-346
75. Harder DR, Belardinelli L, Sperelakis N, Rubio R, Berne RM (1979) Differential effects of adenosine and nitroglycerin on the action potential of large and small coronary arteries. Circ Res 44:176-182
76. Fenton RA, Rubio BR, Berne AM (1982) Effect of adenosine on calcium uptake by intact and cultured vascular smooth muscle. Am J Physiol 242:H797-H804
77. Aversano T, Ouyang P, Silverman H (1991) Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine circulation. Circ Res 69:618-622
78. + channels. Circ Res 80:1-10
79. Nees S, Herzog V, Becker BF, Bock M, Rosiers CD, Gerlach E (1985) The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 80:515-529
80. Matsuda H, Imai S (1990) Effects of adenosine and adenine nucleotides on the diameter of the isolated perfused pig coronary artery (abstract). Jpn J Pharmacol 52 (Suppl II):116
81. Kurtz A (1987) Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol Chem 262:6296-6300
82. Berne RM, Rubio R, Curnish RR (1974) Release of adenosine from ischemic brain: effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res 35:262-271
83. Kitakaze M, Hori M, Sato H, Takashima S, Inoue M, Kitabatake A, Kamada T (1991) Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 69:1402-1408
84. Minamino T, Kitakaze M, Asanuma H, Tomiyama Y, Shiraga M, Sato H, Ueda Y, Funaya H, Kuzuya T, Matsuzawa Y, Hori M (1998) Endogenous adenosine inhibits P-selectin-dependent formation of coronary thrombi during hypoperfusion in dogs. J Clin Invest 101:1643-1653
85. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R (1986) Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 78:760-770
86. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R (1986) Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158:1160-1177
87. Cronstein BN (1991) Adenosine is an autacoid of inflammation: effects of adenosine on neutrophil function. In: Imai S, Nakazawa M (eds) Role of adenosine and adenine nucleotides in the biological system. Elsevier, Amsterdam, pp 515-520
88. Kitakaze M, Hori M, Morioka T, Takashima S, Sato H, Minamino T, Inoue M, Kamada T (1993) Attenuation of 5′-nucleotides and adenosine release in activated human polymorphonuclear leukocytes. Circ Res 73:524-533
89. Belardinelli L, Isenberg G (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287-297
90. Sato H, Hori M, Kitakaze M, Takashima S, Inoue M, Kitabatake A, Kamada T (1992) Endogenous adenosine attenuates beta-adrenoceptor-mediated inotropic response in the hypoperfused canine myocardium. Circulation 85:1594-1603
91. Richardt G, Wassa W, Kranzhofer R, Mayer E, Schöming A (1987) Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res 61:117-123
92. Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291-306
93. 2 receptors prevents myocardial stunning (abstract). Circulation 82:III-37
94. 1-adrenoceptor activity on myocardial stunning in dogs. Circ Res 68:1322-1339
95. Isenberg G, Belardinelli L (1984) Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 55:309-325
96. Isenberg G, Cerbai E, Klockner U (1987) Ionic channels and adenosine in isolated heart cells. In: Gerlach E, Becker BF (eds) Topics and perspective in cardiovascular research. Springer, Berlin, pp 323-335
97. Kitakaze M, Weisman HF, Marban E (1988) Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 77:685-695
98. i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied for the study of ischemia and reperfusion. Circ Res 66:1255-1267
99. Agarwal KC (1987) Adenosine and platelet function. In: Stefanovich V, Okayuz-Baklouti I (eds) Role of adenosine in cerebral metabolism and blood flow. VNU Science, Utrecht, pp 107-124
100. Newman WH, Becker BF, Heier M, Nees S, Gerlach E (1988) Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts. Pflügers Arch 413:1-7
101. Hori M, Inoue M, Kitakaze M, Koretsune Y, Iwai K, Tamai J, Ito H, Kitabatake A, Sato T, Kamada T (1986) Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol 250: H509-H518
102. Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, Koretsune Y, Kitabatake A, Inoue M, Kamada T (1991) Role of oxygen-mediated free radicals in myocardial edema and ischemia in coronary microembolization. Circulation 84:828-884
103. Kitakaze M, Hori M, Takasima S, Morioka T, Minamino T, Inoue M, Kamada T (1993) Superoxide dismutase protects the degradation of myocardial ectosolic 5′-nucleotidase and increases adenosine release during ischemia and reperfusion. Biorheology 30:359-371
104. Takeo S, Tanonaka K, Miyake K, Imago M (1988) Adenine nucleotide metabolites are beneficial for recovery of cardiac contractile force after hypoxia. J Mol Cell Cardiol 20:187-199
105. Engler R (1987) Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia. Fed Proc 46:2407-2412
106. Foker JE, Einzig E, Wang T (1980) Adenosine metabolism and myocardial preservation. J Thorac Cardiovasc Surg 80:506-516
107. Reibel DK, Rovette MJ (1979) Myocardial adenosine salvage rates and restoration of ATP content following ischemia. Am J Physiol 237:H247-H252
108. Isselhard W, Eitenmuller J,- Maurer W, DeVreese A, Reinke H, Czerniak A, Struz J, Herb HG (1980) Increase in myocardial adenine nucleotides induced by adenosine: dosage, mode of application and duration, species differences. J Moll Cell Cardiol 12:619-634
109. Mauser M, Hoffmeister HM, Nienber C, Schaper W (1985) Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog. Circ Res 56:220-230
110. Dole VP (1962) Insulin-like actions of ribonucleic acid, adenylic acid, and adenosine. J Biochem Chem 237: 2758-2762
111. Green A, Newsholme EA (1979) Sensitivity of glucose uptake and lipolysis of white adipoytes of the rat to insulin and effects of some metabolites. Biochem J 180:365-370
112. Schwabe U, Schonhofer PS, Ebert R (1974) Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3′,5′-monophosphate, lipolysis, and glucose oxidation in isolated fat cells. Eur J Biochem 46:536-545
113. Raberger G, Kraupp O, Stuhlinger W Nell G, Chirikdjiam JJ (1970) The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and myocardial metabolism in dogs. Pflügers Arch 317:20-34
114. Mainwaring RD, Mentzer RM Jr (1986) Effects of dipyridamole on myocardial glucose uptake in the newborn lamb. J Surg Res 40:528-533
115. Mashaffey K, Puma JA, Barbagelata A, Casas CA, Lambe L, Orlandi C, Gibbons RJ, Califf RM, Granger CB (1997) Does adenosine in conjugation with thrombosis reduce infarct size? Results from the controlled, randomized AMISTAD Trial. Circulation 6:I-206-I-207
116. Nakayama H, Nanto S, Phara T, Morozumi T, Nagata S, Hoki N, Kitakaze M, Minamino T, Hori M (1999) Intracoronary administration of ATP combined with direct PTCA reduces the size of myocardial infarction?: Cooperative Osaka Adenosine Trial for Acute Myocardial Infarction (abstract). J Am Coll Cardiol 33:376A
117. Kumakura T, Takase K, Terada N, Gelefand EW (1995) Vesnarinone inhibits nucleoside and nucleobase transport. Life Sci 57:75-81
118. Kitakaze M, Fong M, Yoshitake M, Minamino T, Node K, Okuyama Y, Terada N, Kambayashi T, Hori M (1997) Vesnarinone inhibits adenosine uptake in endothelial cells, smooth muscle cells and myocytes, and mediates cytoprotection. J Mol Cell Cardiol 29:3413-3417
119. Kitakaze M, Minamino T, Funaya T, Node K, Shinozaki Y, Mori H, Hori M (1997) Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart. Circulation 95:2108-2114
120. Cronstein BN, Naime D, Ostad E (1993) The antiinflammatory mechanism of methotrexate. J Clin Invest 92:2675-2682
121. Morabito L, Montesinos MC, Schreibman DM, Balter L, Thompson LF, Resta R, Carlin G, Huie MA, Cronstein BN (1998) Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101:295-300
122. Cronstein BN, Eberle MA, Gruber HE, Levin RI (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88:2441-2445
123. Cronstein BN (1996) Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 39:1951-1960
124. Packer M (1988) Neurohumoral interactions and adaptation in congestive heart failure. Circulation 77:721-730
125. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin E (1975) Effects of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022-1036
126. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691
127. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72:561-566
128. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M (1997) Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95:1363-1365
129. Kitakaze M, Funaya H, Minamino T, Node K, Koretsune Y, Komamura K, Sato H, Hori M (1998) A new strategy for the treatment of chronic heart failure: elevation of plasma adenosine levels. Cardiovasc Drug Ther 12:307-309